Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01312051 · ClinicalTrials.gov registry record

Childhood Metabolic Markers of Adult Morbidity in Blacks

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
156
Enrollment target

NCT01312051 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 156 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01312051 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
156 participants
Enrollment target

Study Summary

Blacks are at increased risk for obesity, type 2 diabetes mellitus and cardiovascular disease. A common pathogenetic link among these entities is insulin resistance/hyperinsulinemia. The specific aims of this project are: 1) to compare skeletal muscle lipid content (SMLC) in black vs white children by computed tomography (CT) scan of the mid-thigh, and assess the relationship to in vivo insulin sensitivity; 2) to test the hypothesis that free fatty acid (FFA) - induced insulin resistance is associated with larger increases in intramyocellular lipid (IMCL) in black vs white adolescents; 3) to examine if β-cell insulin secretion in prepubertal black children is more sensitive to the stimulatory effect of FFA than in whites; and 4) to test if the β-cell in black obese adolescents is more susceptible to the lipotoxic effect of FFA compared with whites. The methods to be used are: the well- established CT method as well as Magnetic Resonance Spectroscopy (1H-MRS) to assess SMLC and IMCL; intralipid infusion to elevate circulating FFA levels; the hyperinsulinemic-euglycemic clamp with stable isotopes and indirect calorimetry to measure insulin sensitivity and substrate turnover; the hyperglycemic clamp to assess insulin secretion; DEXA and whole body MRI for body composition assessments.

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2004-07
Est. Completion 2011-09-20

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01312051

The ClinicalTrials.gov registry entry for NCT01312051 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01312051 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01312051 about?

NCT01312051 is a clinical study titled "Childhood Metabolic Markers of Adult Morbidity in Blacks". Blacks are at increased risk for obesity, type 2 diabetes mellitus and cardiovascular disease. A common pathogenetic link among these entities is insulin resistance/hyperinsulinemia. The specific aims of this project are: 1) to compare skeletal muscle lipid content (SMLC) in black vs white children...

What is the current status of trial NCT01312051?

This trial is currently completed. The enrollment target is 156 participants. The study started on 2004-07. Estimated completion is 2011-09-20.

Who is sponsoring clinical trial NCT01312051?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.